RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK)
| Market Cap | 856.81M |
| Revenue (ttm) | 1.95B |
| Net Income (ttm) | 38.11M |
| Shares Out | 66.94M |
| EPS (ttm) | 0.57 |
| PE Ratio | 22.54 |
| Forward PE | 19.10 |
| Dividend | 0.10 (0.78%) |
| Ex-Dividend Date | n/a |
| Volume | 1,597 |
| Average Volume | 1,853 |
| Open | 12.80 |
| Previous Close | 12.80 |
| Day's Range | 12.80 - 12.80 |
| 52-Week Range | 11.20 - 16.40 |
| Beta | -0.06 |
| RSI | 66.08 |
| Earnings Date | Mar 26, 2026 |
About ETR:RHK
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company also operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany. [Read more]
Financial Performance
In 2024, ETR:RHK's revenue was 1.87 billion, an increase of 7.67% compared to the previous year's 1.73 billion. Earnings were 43.35 million, an increase of 11.98%.
Financial StatementsNews
Rhoen-Klinikum's Q3 2025: Solid Results Drive Growth
Amidst a dynamic healthcare environment, RHÖN-KLINIKUM AG showcases resilience with rising revenues and strategic foresight, despite economic and regulatory hurdles. Jetzt den vollständigen Artikel le...
Rhoen-Klinikum Shines in H1 2025 with Strong Performance
RHÖN-KLINIKUM AG showcases resilience with a 7.5% revenue rise, navigating challenges with a focus on digital transformation and strategic partnerships. Jetzt den vollständigen Artikel lesen
Rhoen-Klinikum Steady in Q1 2025, Confirms Positive Outlook
In Q1 2025, RHÖN-KLINIKUM AG treated over 240,000 patients, achieving an 8.3% revenue increase, despite economic challenges. Strategic partnerships and a focus on quality care position them for future...
Rhoen-Klinikum's Prof. Kaltenbach Exits After Stellar Year
RHÖN-KLINIKUM AG celebrates a thriving year, with revenues soaring and patient numbers climbing, as it sets ambitious targets for a sustainable future. Jetzt den vollständigen Artikel lesen
EQS-News: RHÖN-KLINIKUM AG once again reports a successful financial year – CEO Prof. Kaltenbach leaves the Board of Management as planned
EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Annual Report/Annual Results RHÖN-KLINIKUM AG once again reports a successful financial year – CEO Prof. Kaltenbach leaves the Board of Manage...
Rhoen-Klinikum Shines: Strong 9-Month Performance, Outlook Confirmed
RHÖN-KLINIKUM AG has shown robust growth in 2024, with significant increases in revenue, profit, and patient numbers, underscoring its position as a leading healthcare provider in Germany. Jetzt den v...
RHÖN-KLINIKUM AG: Strong H1 2024 Performance, Confident Outlook Ahead
RHÖN-KLINIKUM AG saw a robust first half of 2024, with revenues climbing 6.5% to 775.5 million euros and profits soaring 68.9% to 20.6 million euros, despite a tough market. Patient numbers and EBITDA...
EQS-News: First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed
EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Half Year Results/Miscellaneous First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed 08.08.2024 / 09:0...